Drugsniper, a tool to exploit loss-of-function screens, identifies CREBBP as a predictive biomarker of VOLASERTIB in small cell lung carcinoma (SCLC)

  1. Carazo, F.
  2. Bértolo, C.
  3. Castilla, C.
  4. Cendoya, X.
  5. Campuzano, L.
  6. Serrano, D.
  7. Gimeno, M.
  8. Planes, F.J.
  9. Pio, R.
  10. Montuenga, L.M.
  11. Rubio, A.
Aldizkaria:
Cancers

ISSN: 2072-6694

Argitalpen urtea: 2020

Alea: 12

Zenbakia: 7

Orrialdeak: 1-18

Mota: Artikulua

DOI: 10.3390/CANCERS12071824 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus